Legal Representation
Attorney
Chelsea E. Carbone
USPTO Deadlines
Next Deadline
93 days remaining
NOA E-Mailed - SOU Required
Due Date
April 22, 2026
Extension Available
Until October 22, 2026
Application History
22 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 9, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 9, 2025 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Oct 8, 2025 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Oct 8, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 20, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 20, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Mar 19, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Mar 19, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 22, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 27, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 27, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 7, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 25, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 24, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 24, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 24, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Apr 26, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Apr 26, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Apr 26, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Apr 25, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 26, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 29, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for preventing or treating diseases of the cardiovascular system, diseases of the endocrine system, diseases of the gastrointestinal and digestive system, diseases of aging, diseases of the blood, diseases of the brain, diseases of the ear, nose and throat, diseases of the liver, diseases of the kidney, diseases of the nervous system, cancer, metabolic diseases, diseases of the immune system, diseases of the respiratory system, diseases of the musculoskeletal system, diseases of the genitourinary system, diseases of the skin, diseases of the eye, diseases of the auditory system, diseases of the reproductive system, diseases of pregnancy, psychiatric diseases, nutritional diseases, hereditary diseases, allergic diseases and infectious diseases; pharmaceutical preparations for use in angiology, cardiology, endocrinology, gastroenterology, genetics, geriatrics, gynecology, hematology, hepatology, immunology, nephrology, neurology, obstetrics, oncology, pulmonology, pneumology, respirology, rheumatology, anesthesiology, urology, dermatology, gynecology, orthopedics, ophthalmology, infectiology, and psychiatry, particularly for preventing or treating diseases of the cardiovascular system, diseases of the endocrine system, diseases of the gastrointestinal and digestive system, diseases of aging, diseases of the blood, diseases of the brain, diseases of the ear, nose and throat, diseases of the liver, diseases of the kidney, diseases of the nervous system, cancer, metabolic diseases, diseases of the immune system, diseases of the respiratory system, diseases of the musculoskeletal system, diseases of the genitourinary system, diseases of the skin, diseases of the eye, diseases of the auditory system, diseases of the reproductive system, diseases of pregnancy, psychiatric diseases, nutritional diseases, hereditary diseases, allergic diseases and infectious diseases; pharmaceutical preparations for use in pediatric, adolescent, adult, geriatric, inpatient, outpatient, acute, emergency, family, and preventative medicine, particularly for preventing or treating diseases of the cardiovascular system, diseases of the endocrine system, diseases of the gastrointestinal and digestive system, diseases of aging, diseases of the blood, diseases of the brain, diseases of the ear, nose and throat, diseases of the liver, diseases of the kidney, diseases of the nervous system, cancer, metabolic diseases, diseases of the immune system, diseases of the respiratory system, diseases of the musculoskeletal system, diseases of the genitourinary system, diseases of the skin, diseases of the eye, diseases of the auditory system, diseases of the reproductive system, diseases of pregnancy, psychiatric diseases, nutritional diseases, hereditary diseases, allergic diseases and infectious diseases; pharmaceutical preparations for the treatment of infectious, deficiency, excess, acquired, idiopathic, iatrogenic, genetic, hereditary, and physiological diseases
Classification
International Classes
005